SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-22-007358
Filing Date
2022-03-21
Accepted
2022-03-21 16:05:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 185668
2 form424b3_001.jpg GRAPHIC 17256
3 form424b3_002.jpg GRAPHIC 16948
  Complete submission text file 0001493152-22-007358.txt   234121
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 424B3 | Act: 33 | File No.: 333-257104 | Film No.: 22755774
SIC: 2834 Pharmaceutical Preparations